Core Insights - Chipotle Mexican Grill (CMG) is expected to report quarterly earnings of $0.32 per share, reflecting a 5.9% decline year-over-year, while revenues are forecasted to reach $3.1 billion, indicating a 4.4% increase compared to the previous year [1] Earnings Estimates - The consensus EPS estimate has been revised downward by 0.4% over the past 30 days, indicating a collective reassessment by analysts [2] - Revisions to earnings estimates are crucial for predicting investor actions, as empirical research shows a strong correlation between earnings estimate trends and short-term stock price performance [3] Revenue Metrics - Analysts estimate 'Revenue- Food and beverage' to be $3.08 billion, representing a 4.2% year-over-year increase [5] - The forecast for 'Revenue- Delivery service' is $16.06 million, which reflects an 11.8% decline from the same quarter last year [5] Restaurant Operations - The estimated number of 'Company-operated restaurants at end of period' is 3,846, up from 3,530 in the same quarter last year [6] - Analysts predict a 'Comparable restaurant sales increase' of -2.8%, a significant drop from the previous year's 11.1% [6] New Openings and Sales - The consensus is that 'Company-operated restaurants opened' will total 65, compared to 52 in the prior year [7] - The projected 'Company-operated restaurants at beginning of period' is 3,781, up from 3,479 in the same quarter last year [7] - The estimated 'Average restaurant sales - TTM' is $3.14 million, slightly down from $3.15 million year-over-year [7] Stock Performance - Over the past month, Chipotle shares have returned +3.3%, while the Zacks S&P 500 composite has seen a +5.4% change [8] - CMG currently holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [8]

Core Insights - Analysts project Alaska Air Group (ALK) will report quarterly earnings of $1.56 per share, a decline of 38.8% year over year, with revenues expected to reach $3.66 billion, an increase of 26.3% from the same quarter last year [1]. Earnings Projections - Over the last 30 days, there has been a downward revision of 4.1% in the consensus EPS estimate for the quarter, indicating a collective reconsideration by covering analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Metrics Estimates - Revenue from 'Mileage Plan other' is estimated at $219.52 million, reflecting a year-over-year change of +26.2% [5]. - 'Revenue- Cargo and other' is projected to reach $137.72 million, indicating a significant increase of +91.3% from the prior-year quarter [5]. - The 'Passenger Load Factor' is expected to be 85.2%, up from 84.1% a year ago [5]. Operational Metrics - Analysts estimate 'Available seat miles (ASM)' at 22.96 billion, compared to 18.20 billion from the previous year [6]. - The consensus for 'Revenue passenger miles (RPM)' stands at 19.59 billion, up from 15.31 billion year-over-year [6]. - 'Fuel gallons' are forecasted to reach 285 million, an increase from 219 million gallons a year ago [7]. Additional Insights - 'ASMs per fuel gallon' are expected to be $79.2, down from $83.1 a year ago [8]. - 'Revenue passengers' are projected at 14.82 billion, compared to 11.89 million from the previous year [8]. - The average full-time equivalent employees (FTEs) is expected to reach 29,259, up from 23,368 year-over-year [8]. Stock Performance - Over the past month, shares of Alaska Air have returned +13.3%, outperforming the Zacks S&P 500 composite's +5.4% change [9]. - Currently, ALK holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the overall market in the near future [9].

Core Viewpoint - Boston Scientific (BSX) is expected to report quarterly earnings of $0.72 per share, reflecting a 16.1% increase year-over-year, with revenues projected at $4.89 billion, an 18.7% increase compared to the previous year [1]. Financial Performance Estimates - Analysts anticipate 'Net Sales- MedSurg- Worldwide' to reach $1.68 billion, indicating a 13.1% increase from the prior-year quarter [4]. - The estimated 'Net Sales- Cardiovascular- Worldwide' is projected at $3.21 billion, representing a 21.7% increase year-over-year [4]. - 'Net Sales- Cardiovascular- Cardiology- Worldwide' is expected to be $2.52 billion, showing a 23.3% increase from the previous year [5]. - 'Net Sales- Cardiovascular- Peripheral Interventions- Worldwide' is forecasted at $689.56 million, indicating a 16.9% year-over-year change [5]. - 'Geographic Revenue- U.S.' is likely to reach $3.06 billion, reflecting a 24.1% increase year-over-year [6]. - 'Net Sales- Cardiovascular- Peripheral Interventions- International' is projected at $309.92 million, indicating a 10.3% increase from the prior year [6]. - 'Net Sales- MedSurg- Neuromodulation- United States' is expected to be $220.82 million, showing a 3.2% increase year-over-year [7]. - 'Net Sales- MedSurg- Neuromodulation- International' is forecasted at $70.31 million, reflecting a 3.4% increase [7]. - 'Net Sales- MedSurg- Endoscopy- United States' is projected at $445.09 million, indicating a 7.3% increase year-over-year [8]. - 'Net Sales- MedSurg- Endoscopy- International' is expected to reach $273.79 million, reflecting a 4.9% increase [8]. - 'Net Sales- MedSurg- Urology- United States' is forecasted at $492.40 million, indicating a significant 35.7% increase year-over-year [8]. - 'Net Sales- MedSurg- Urology- International' is projected at $177.83 million, reflecting a 9.8% increase [9]. Market Performance - Over the past month, shares of Boston Scientific have returned +3.2%, compared to the Zacks S&P 500 composite's +5.4% change [9]. - Currently, BSX holds a Zacks Rank 2 (Buy), suggesting potential outperformance in the near future [9].

Core Insights - Hasbro (HAS) is expected to report quarterly earnings of $0.76 per share, reflecting a 37.7% decline year-over-year, with revenues forecasted at $872.98 million, down 12.3% from the previous year [1] Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised upward by 1.1%, indicating analysts' reassessment of their initial forecasts [2] - Prior to earnings releases, revisions to earnings projections are crucial for predicting investor behavior, as studies show a strong correlation between earnings estimate trends and short-term stock performance [3] Revenue Forecasts - Analysts estimate 'External Net Revenues- Entertainment' at $19.18 million, a 2% increase year-over-year [5] - 'External Net Revenues- Consumer Products' is projected to be $413.93 million, reflecting a 21.1% decrease from the prior-year quarter [5] - 'External Net Revenues- Wizards of the Coast and Digital Gaming' is expected to reach $459.57 million, indicating a 1.7% increase year-over-year [6] - The consensus for 'Wizards of the Coast and Digital Gaming Net Revenues- Tabletop Gaming' stands at $337.95 million, showing a 9.9% increase from the previous year [6] - 'Wizards of the Coast and Digital Gaming Net Revenues- Digital and Licensed Gaming' is estimated at $124.14 million, a 14% decline from the prior-year quarter [7] Operating Profit - Analysts project 'Operating profit (loss)- Wizards of the Coast and Digital Gaming' to be $185.99 million, down from $247.10 million in the previous year [7] Stock Performance - Over the past month, Hasbro shares have increased by 13.6%, outperforming the Zacks S&P 500 composite, which rose by 5.4% [7] - Currently, Hasbro holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [7]

Core Viewpoint - Analysts project that Amphenol (APH) will report quarterly earnings of $0.66 per share, reflecting a 53.5% year-over-year increase, with revenues expected to reach $4.97 billion, a 37.6% increase from the same quarter last year [1] Earnings Estimates - There has been a 0.6% upward revision in the consensus EPS estimate for the quarter over the last 30 days, indicating analysts' reassessment of their initial forecasts [2] - Revisions to earnings projections are crucial for predicting investor behavior and are strongly linked to short-term stock price performance [3] Revenue Projections - Analysts forecast 'Net Sales- Harsh Environment Solutions' to reach $1.32 billion, a 25.7% increase year-over-year [5] - 'Net Sales- Interconnect and Sensor Systems' is projected at $1.18 billion, reflecting a 5.7% increase from the prior year [5] - 'Net Sales- Communications Solutions' is expected to reach $2.48 billion, indicating a significant year-over-year change of 71.4% [5] Operating Income Estimates - 'Operating Income- Interconnect and Sensor Systems' is expected to be $224.58 million, up from $203.30 million in the same quarter last year [6] - 'Operating Income- Communications Solutions' is projected to reach $672.65 million, compared to $350.60 million in the previous year [6] - 'Operating Income- Harsh Environment Solutions' is anticipated to be $317.77 million, an increase from $259.60 million year-over-year [7] Stock Performance - Amphenol shares have increased by 9.1% over the past month, outperforming the Zacks S&P 500 composite, which rose by 5.4% [7] - With a Zacks Rank 2 (Buy), Amphenol is expected to outperform the overall market in the near future [7]

Core Viewpoint - ServiceNow (NOW) is expected to report quarterly earnings of $3.54 per share, a 13.1% increase year-over-year, with revenues projected at $3.12 billion, reflecting an 18.8% year-over-year growth [1]. Earnings Estimates - The consensus EPS estimate has been revised down by 0.4% in the last 30 days, indicating a reassessment by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and stock price performance [3]. Revenue Projections - Analysts estimate 'Revenues- Professional services and other' to reach $88.78 million, a 4.5% year-over-year increase [5]. - 'Revenues- Subscription' is projected to be $3.03 billion, indicating a 19.3% year-over-year growth [5]. - 'Current Remaining Performance Obligations (cRPO) - GAAP' is expected to be $10.48 billion, up from $8.78 billion a year ago [5]. - 'Remaining Performance Obligations (RPO) - GAAP' is estimated at $22.11 billion, compared to $18.60 billion from the previous year [6]. Profitability Metrics - 'Gross Profit (Non-GAAP)- Subscription' is anticipated to be $2.53 billion, an increase from $2.16 billion in the same quarter last year [6]. - 'Gross Profit (Non-GAAP)- Professional services and other' is projected at $9.05 million, down from $14.00 million year-over-year [7]. Stock Performance - ServiceNow shares have decreased by 2.3% over the past month, contrasting with a 5.4% increase in the Zacks S&P 500 composite [7].

Core Insights - Analysts forecast Infosys (INFY) will report quarterly earnings of $0.19 per share, reflecting a year-over-year increase of 5.6% [1] - Expected revenues for the quarter are projected at $4.84 billion, indicating a 2.6% increase compared to the same quarter last year [1] Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised upward by 1.3%, indicating a collective reassessment by analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3] Key Metrics - Analysts estimate 'Employee Metrics - Software Professionals' will reach 256,265, down from 298,123 in the same quarter last year [5] - The expected 'Utilization - Including trainees - Consolidated' is projected at 82.8%, compared to 83.9% reported in the same quarter last year [5] - The consensus for 'Utilization - Excluding trainees - Consolidated' is 84.9%, down from 85.3% in the previous year [6] - The estimate for 'Employee Metrics - Sales & Support' stands at 14,344, compared to 17,209 a year ago [6] Stock Performance - Infosys shares have changed by +0.2% in the past month, while the Zacks S&P 500 composite has moved +5.4% [6] - With a Zacks Rank 2 (Buy), INFY is expected to outperform the overall market in the near term [6]

Core Insights - Arbor Realty Trust (ABR) is expected to report quarterly earnings of $0.29 per share, reflecting a decline of 35.6% year over year [1] - Analysts forecast revenues of $237.24 million, indicating a decrease of 20.2% compared to the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, suggesting a reassessment of projections by covering analysts [1] Revenue Estimates - Interest income is projected to reach $237.24 million, down 20.2% from the prior-year quarter [4] - Other revenue from gains on sales, including fee-based services, is estimated at $13.77 million, reflecting a decline of 21.1% year over year [4] - Servicing revenue is expected to be $26.77 million, indicating a decrease of 10.5% from the previous year [4] Additional Revenue Metrics - Analysts estimate 'Other revenue- Mortgage servicing rights' at $10.47 million, suggesting a year-over-year decline of 28% [5] - Over the past month, Arbor Realty Trust shares have gained 11%, outperforming the Zacks S&P 500 composite, which increased by 5.4% [5] - Arbor Realty Trust holds a Zacks Rank 3 (Hold), indicating expected performance in line with the overall market [5]

Core Viewpoint - Analysts project that Thermo Fisher Scientific (TMO) will report quarterly earnings of $5.22 per share, reflecting a 2.8% decline year over year, with revenues expected to reach $10.65 billion, a 1% increase from the same quarter last year [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 0.2% over the past 30 days, indicating a collective reassessment by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Revenues- Laboratory Products and Biopharma Services' at $5.74 billion, a decrease of 0.2% year over year [5]. - 'Revenues- Specialty Diagnostics' are projected to reach $1.14 billion, indicating a 2.5% increase year over year [5]. - 'Revenues- Life Sciences Solutions' are expected to be $2.40 billion, reflecting a 2.1% increase year over year [5]. - 'Revenues- Analytical Instruments' are estimated at $1.79 billion, showing a 0.7% increase year over year [6]. - 'Geographic Revenues- Customer Location- North America' is projected at $5.56 billion, a 0.5% increase from the prior year [6]. - 'Geographic Revenues- Customer Location- Asia-Pacific' is estimated at $1.98 billion, reflecting a 0.4% increase year over year [7]. - 'Geographic Revenues- Customer Location- Other regions' is expected to reach $391.38 million, indicating a 3.3% increase year over year [7]. - 'Geographic Revenues- Customer Location- Europe' is projected at $2.69 billion, suggesting a 0.9% increase year over year [8]. Stock Performance - Over the past month, shares of Thermo Fisher have returned +8.3%, outperforming the Zacks S&P 500 composite's +5.4% change [8]. - Currently, TMO holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the overall market in the near future [8].

Wall Street analysts expect Alphabet (GOOGL) to post quarterly earnings of $2.14 per share in its upcoming report, which indicates a year-over-year increase of 13.2%. Revenues are expected to be $79.25 billion, up 11.1% from the year-ago quarter.The current level reflects an upward revision of 1.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Before a company ...